FDA Announces Class I Recall for Insulet Omnipod Insulin Pump Pods
The U.S. Food and Drug Administration (FDA) has issued a Class I recall, its most severe category, for certain Insulet Omnipod Insulin Management System pods. This recall applies to Omnipod 5, Omnipod DASH, and Omnipod Eros pods, signifying that their continued use could result in serious injury or death. The FDA's classification highlights the critical nature of this safety alert for users of these insulin delivery systems.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.